Since the pioneering" studies of Everett, Sawyer and Markee (I) it has been ~enerally accepted that the central nervous system (CNS) regulates the secretion of the pituitary gonadotropins, luteinJzinff hormone (LH) and follicle stimulatin~ hormone (FSH). Ilowever, great gaps still exist in our understandinl~ of the neural mechanisms that regulate the secretion of these hormones. The purpose of this review is to provide the reader with a concise overview of this topic. Gaps, inconsistencies and future directions of this area of research are also presented.
ANATOMICAL CONSIDERATIONS
The central nervous system communicates with the anterior pituitary throu~,h a vascular route. Specialized neurons within the preoptico-hypothalamus (a neural re~ion located in the ventral portion of the dJencephalon) synthesize the decapeptide, luteinizing hormone releasing, hormone (LHRH) (2) (3) (4) . LHRH is secreted from neuronal terminals into a specialized capillary network that surrounds the median eminence, a circumventricular or~,an. Followin~ entry into the pituitary portal vAsculature, this neurohormone is delivered to the anterior pituitary (5) where it interacts with pituitary gonadotropes and stimulates the synthesis and release of LH and FSH. Since LH and FSH are secreted in pulses, it is assumed that each ~'onadotropin pulse occurs as a result of a pulsatile discharR'e of hypothalamic LHRH (6) . Thus, an important feature of communication between the CNS and the pituitary is the pattern with which it occurs.
LHRH PULSE MODES
Indeed, the pituitary gland responds onl~ to pulsatile modes of LHRH delivery and exhibits the phenomenon of down-regulation when exposed to a "square-wave" of LHRH (6) . Hypogonadotropic hypogonadism produced in female rhesus monkeys by placement of extensive radiofrequencv lesions in the medial basal hypothalamus (MAR) may be reversed and ovulatory cyclicity restored by pulsatile but not continuous infusion of LHRN (6, 7) . In addition to an absolute requirement for a pulsatile mode of LHRH exposure, pituitary reponses differ depending" upon I,HRH pulse frequency. Slower LHRR pulse frequencies elicit a g'reater FSH/LH release ratio whereas increased frequencies result in a greater LH/FSH ratio (6, 8) . Alterations in LNRH pulse frequency have been proposed as the mechanism by which a sinl~le releasing, hormone ~,overns the release of two pituitary gonadotropins (8) . In addition, pulse amplitude and duration of LHRH may also be an important means of information transmission (9) . Thus, in our developing neuroendocrine model, we envision LHRH neurons, located in the ventral portion of the brain, to discharR'e quanta of LHRH in a pulsatile fashion to stimulate gonadotropin synthesis and release.
The frequency and amplitude of these pulses affects the type of pituitary response.
What dictates the frequency of hypothalamie LHRH discharges? The existing, endocrine milieu appears to be an important factor.
LHRH pulse frequency varies during the ovulatory cycle (I0). Gonadectomy increases LHRH pulse releases, which result in elevated levels of LHRH in pituitary stalk blood and a rise in perioheral gonadotropin concentrations (IlL Replacement of gonadal hormones to castrates slows LHRH pulse frequency, reduces the rate of pituitary ~onadotropin secretion and results in a reduction of circulating' LH and FSH levels (II). Prolonged exposure to high physiologic levels of estradiol reverses this inhibitory effect upon hypothalamic LHRH pulse frequency and results in a surge of ~'onadotropins (II). Alteration in LHRH pulse frequency induced by the hormonal milieu serves as a prime example of neuroendocrine transduction. Circulating levels of gonadal steroid hormones interact with steroidsensitive neural tissue (12) . As a result of steroid-neuronal interactions, firin~ rates of certain hypothalamic neuronal systems are affected (13, 14) . Transduction of endocrine (gonadal steroids) to neurophysiological (firin~ rates of estradiol-sensitive tissue) signals results in an alteration in LHRH pulse frequencv and, therefore, pituitary gonadotropin secretion.
How and where does the transduction of steroidal to neurophysiolo¢ical information occur? Distinct neuroanatomical regions play important roles in regulation of gonadotropin release. Studies that employ electrical recording, neural disconnections or lesions, and electrical and electrochemical stimulations have clearly implicated a broad expanse of neuronal tissue within the preoptico-hyDothalamus as being" critically involved in the transduction phenomenon (15, 16) . The neuroanatomical boundaries of this area are: the rostral aspect of the preoptic area (above the optic chiasm) throu~,h the hypothalamus and funnellin~ caudally toward the median eminence (above the pituitary stalk). The majority of LHRH-producin¢. cell bodies are located within the preoptic area (2) (3) (4) 15) . Ablation of these cell bodies or placement of a surgical cut between the preoptic area and the medial basal hypothalamus blocks the occurrence of the midcycle ~onadotropin surge but not steroid-induced reductions in ~'onadotropin secretion. This information suggests that distinct areas of the preoptico-hvpothalamus regulate different ~onadotropic responses to ~,onadal steroids. Rostral areas appear to control positive feedback actions (i.e., the midcycle ~onadotropin sure, e) whereas steroid-modulated gonadotropin negative feedback is focused within the basal hypothalamus (15, 16) . Thus, the frequency of LHRH release into the pituitary portal system is influenced by the surrounding hormonal milieu. The CNS monitors the existin~ endocrine state and alters the firin~ rates of LHRH neurons within the preopticohypothalamus.
LHRH NEURON NEUROTRANSMITTERS
What is the neuropharmacologic basis for transduction of endocrine to neurophysiological information at the level of the hypothalamus? The hypothalamus contains significant concentrations of a variety of neurotransmitters including, dopamine, norepinephrine and epinephrine (17) (18) (19) . Further, dense concentrations of adrener~,ic receptor sites are located within the preoptico-hypothalamus (20) (21) (22) (23) . These transmitter systems are influenced by the surroundin~ endocrine environment. Gonadal steroids alter the concentration and turnover rates of many neurotransmitters and their receptors in the CNS and elsewhere (15) (16) (17) (24) (25) (26) . Hormonally modulated chan~es in the activitv of tyrosine hydroxylase (the rate limiting, enzyme in catecholamine biosynthesis; 27) and monoamine oxidase (28) have also been demonstrated. Althou~h the hypothalamus is rich in catecholaminer~,ic activity, most (80%) of these neurotransmitters are synthesized by extrahypothalamic neurons (29, 30) . Noradrener~ic cell bodies located in the lateral tegmentum nucleus, tractus solitarius and dorsal motor nucleus of vagus project to the preoptico-hypothalamus via the ventral te~,mental pathway and the medial forebrain bundle and innervate virtually all hypothalamic nuclei (29, 31) . These midbrain catecholaminergic cell bodies have been shown to regulate LHRH release in rats (32, 33) . Further support for a role of midbrain catecholaminer~ic neurons in the control of reproductive processes is provided by the observation that 40-80% concentrate estradiol (34) . Neurons that concentrate 3H-estradiol have also been identified within the preoptic area, anterior hypothalamic area, arcuate nucleus and median eminence (12) . Many hypothalamic neurons that concentrate estrad{ol also stain positively for tyrosine hydroxylase (35) .
Thus, ample neuroanatomical evidence exists to implicate extrahypothalamic catecholaminergic neurons in the regulation of pulsatile discharges of hypothalamic LHRH.
Furthermore, disruption or reduction in ~ adrener~ic neurotransmission by o methyl-p-tyrosine injection (36) , reserpine treatment (37), adrenergic receptor blockade (38) , or opiate administration (39) (to reduce catecholaminer~ic turnover) inhibits pulsatile LH secretion in castrate animals or blocks estradiol-induced LH surge releases.
An o adrenergic link in the activation of the LHRH neuron is also supported by studies in which norepinephrine or epinephrine, injected into the Ill ventricle of estradiol-primed rats, causes a release of pituitary LH (40) (41) (42) . Estradiol-induced increases in hypothalamic LHRH release (43) 
At the level of the median eminence, ~2 adrenoreceptors are most prevalent (21) (22) (23) . Combined, this information suggests that a multi-synaptic, o adrenergic neuronal network is involved in the transduction of gonadal steroid to electrical to neurohumoral information. Extrahypothalamic and hypothalamic neurons monitor circulating levels of ~,onadal steroids (estradiol) and dictate (through alpha adrener~fic neurotransmission) the frequency of pulsatile discharges of LHRH from hypothalamic neurons and therefore the release of gonadotropins from the pituitary.
In addition to modulation of LHRH pulse frequency, gonadal steroids appear to determine whether a neurophysiological or neuropharmacolo~'ical manipulation of a particular brain region will stimulate or inhibit pituitary LH release. Electrical stimulation of the mesencephalic noradrenergic pathway in ovariectomized (ovx) rats results in the suppression of LH pulses (45) . Stimulation of this same area in steroidprimed, ovx animals fails to suppress LH pulses. A similar finding has been reported with stimulation of the arcuate nucleus within the hypothalamus (46) . Further, injections of NE into the third ventricle of ovx rats suppresses LH pulsatility while a similar injection in steroid-primed animals causes a release of LH (40, 42, 47) . Effects of such treatments upon pituitary FSH secretion have not been reported. Examination of the influence of a neuropharmacolo~,ic manipulation or a neurally active dru~f must be carefully controlled with regard to steroid milieu. Opposite effects may be elicited in test subjects exposed to identical treatments during different reproductive states or simply by the injection of estradiol. In spite of information available about the effects of ~onadal hormones upon a variety of neurophvsiolo~fical and neuropharmacological parameters, our understanding of the neurotransmitter systems that regulate LH and especially FSH release throu~fh the secretion of hypothalamic LHRH is incomplete.
INTERPRETATION OF NEUROPHARMACOLOGIC STUDIES
Many studies that have attempted to determine the neuropharmacologic factors involved in the regulation of gonadotropin release have been contradictory. A variety of drugs have been injected into test animals and the effect upon ~,onadotropin release has been monitored. Many of the neurochemicals tested lacked receptor specificity. These substances may have served as precursors to other neurotransmitters (i.e., infused dopamine or norepinephl'ine being converted to norepinephrine or epinephrine). Thus, if dopamine is infused into the CNS, it cannot be determined if changes in gonadotropin secretion are due to activation of dopaminergic or noradrenergic systems. Another source of confusion has been the lack of knowled~fe of the effects of dru~s at the receptor site. Initially, adrenergic receptors were classified according, to their location. Alpha I adrenoreceptors were thou~fht to be localized postsynaptically and o 2 receptors were hypothesized to be presynaptic autoreceptors (48) (49) (50) (51) . These receptors exhibit different affinities for specific neuropharmacolo{~ic a~fents. For instance, clonidine, an adrenergic agonist, binds with much ~freater affinity to n 2 receptors. Hypothetically, activation of these presynaptic receptors with clonidine would decrease endogenous neurotransmitter release. Norepinephrine exhibits equal affinities for ~I and 2 receptors. Phenylephrine exhibits a preferential affinity for ~I receptors.
Shortly after it was proposed, the hypothesis was refuted that anatomical location was the basis upon which "I and c~ 2 adrenoreceptors were segregated (20) . Destruction of presynaptic terminals by injection of 6-OH dopamine or lesions of noradrener~ic cell bodies was not accompanied by a rapid decline in ~2 binding, in spite of the degeneration of presynaptic neurons. It is now well accepted that ~I and "2 receptors are present postsynapticallv (52) . Although the physiologic role of presynaptic receptors is in question (53) , it has been demonstrated that activation of putative presynaptic autoreceptors by -al~onists reduces neurotransmitter release (51, 53) . Saturation of presynaptic receptors with antagonists actually increases endogenous neurotransmitter release (55) . The preopticohypothalamus contains c~ I and c~ 2 receptors, with the latter preferentiallv located in the arcuate-median eminence region (21) (22) (23) . Thus, conflictinl~ reports of hormonal responses to neuropharmacolo~ic manipulation may be due not only to the lack of specificity of the drug, but a presynaptic effect of the drug as well. Furthermore, a variety of other neurotransmitters have been reported to affect the LHRH neuron directly, or indirectly by an influence upon the activity of catecholaminergic neurons (15, 16) . Receptors for many other neurotransmitter systems are heterogeneous, both in ligand binding and post-receptor events (56) (57) (58) (59) (60) (61) . Great care must be exerted in the execution and interpretation of neuroendocrine experiments performed with all neurotransmitter agonists and antagonists.
FSH VS LH REGULATION
In addition to the problems that surround the study of the neuropharmacologic control of the LHRH neuron, another dilemma exists. Many investil~ators have Dresented evidence that the neuroendocrine mechanisms that regulate LB and FSH are dissimilar (62) (63) (64) (65) (66) (67) (68) (69) .
For instance, disruption of cv adrenergic neurotransmission by the injection of drugs that affect catecholamine biosynthesis (62) or turnover (64) results in a rapid diminution in LH but not FSH pulse frequency.
Further, alterations in the rate of pituitary LII secretion are accompanied by chan~,es in catecholamine turnover within specific hypothalamic nuclei (16) . Alterations in the rate of pituitary FSH secretion are not accompanied by changes in hypothalamic catecholamine content (70, 71) . The neurotransmitter systems that influence the release of pituitary FSH are unknown.
Although little is known about the neuroendocrine mechanisms that regulate FSB secretion, it is apparent that the release of this ~'onadotropin is regulated by neural mechanisms. Pulsatile FSH release is not observed from pituitary tissue in vitro (72) . Stalk sections or total ablation of the arcuate-median eminence re~ion does not result in continued FSH release (6, 7) . Electrical stimulation of CNS ref~ions (apart from those that regulate LH release) results in a selective release of FSH (73) . Ablation (74), implantation of prostaglandins (75) and deafferentation (76, 77) studies support the hypothesis that a separate neural re~ion regulates FSH secretion.
As mentioned above, the frequency of LNRH pulse releases influences the relative proportions of LH and FSH released. However, recent studies su~,est that many of the elevations in FSH secretions cannot be explained on the basis of alterations in LHRH pulse frequency. Indeed, a controversy exists as to the involvement of LI-IRH in the release of FSH. Immunoneutralization of LHRN (62, 66, 78) or iniection of LHRH antaRonists (79, 80) exerts dramatic effects upon LH pulsatility in serum while not affecting FSH. Contrary to these findings, increases in pituitary portal blood immunoreactive LHRH concentrations have been observed during times of selective FSH releases (during estrus or after ovariectomy) (11,81). Furthermore, data are available to suggest that a specific releasing hormone (distinct from LHRH) re~'ulates the release of FSH (82, 87) . Cyclic fluctuations in hypothalamic FSH releasing, activity have been observed without changes in LHRR bioactivity (84) (85) (86) (87) . The neuroanatomica] location of neurons that synthesize a putative FSFI releasin~ hormone remains a mvsterv.
Thus, the reproductive neuroendocrine system ~)rovides a unique model that may be employed to study the interaction between gonadal steroids, central nervous tissue, neurosecretory cells and anterior pituitary hormones. Research efforts in reproductive neuroendocrinology have elucidated the mechanisms that regulate the release of pituitary LB. Progress in our understanding of the neural regulation of FSH secretion is occurrin~ at a much slower rate. Information about the interactions between ~onadal steroids, nervous tissue, neurotransmitter systems and the hyoothalamic LBRH neuron is accumulating steadily. With the availability of refined techniques such as neural microdissection methods, specific neuroDharmacolo~ic agonists and antagonists, single unit neural recordings and immunohistochemistry, the gaps and inconsistencies that presently exist will be overcome.
